Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

Masafumi Ikeda, Masatoshi Kudo, Hiroshi Aikata et al.|Journal of Gastroenterology|2017

Cited by 91